Curtiss-Wright Capitalized R&D decreased by 13.6% to $52.53M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.6%, from $60.82M to $52.53M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase reflects higher investment in R&D that is being deferred for tax purposes, potentially signaling future innovation capacity.
This represents the tax benefit associated with research and development costs that have been capitalized for tax purpos...
Common among technology-heavy industrial firms; peers with higher R&D intensity will show larger balances here.
other_deferred_tax_asset_capitalized_rd| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $23.79M | $39.46M | $60.82M | $52.53M |
| QoQ Change | — | — | +65.9% | +54.1% | -13.6% |
| YoY Change | — | — | +65.9% | +54.1% | -13.6% |